Deerfield Management Discloses Stake In Post-IPO Audentes Therapeutics (BOLD)

Page 12 of 14

Page 12 of 14 – SEC Filing
Exhibit List
Exhibit A.  Joint Filing Agreement.
Exhibit B.  Item 8 Statement.
Exhibit C.  Power of Attorney (1).
(1) Power of Attorney previously filed as Exhibit 24 to a Form 3 with regard to Editas Medicine, Inc. filed with the Securities and Exchange Commission on February 2, 2016 by Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt HIF, L.P., Deerfield Private Design Fund III, L.P. and James E. Flynn.

Follow Audentes Therapeutics Inc. (NASDAQ:BOLD)

Page 12 of 14